2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, Richard Stephens et al.|European Heart Journal|2022Cited by 2.7k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, Teresa López‐Fernández et al.|European Heart Journal - Cardiovascular Imaging|2022Cited by 486
Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyJohann Bauersachs, Karen Sliwa, Tobias König et al.|European Journal of Heart Failure|2019Cited by 435
Cardio-Oncology Services: rationale, organization, and implementationPatrizio Lancellotti, Riccardo Asteggiano, Thomas Suter et al.|European Heart Journal|2018Cited by 303
Current Management of Patients with Severe Acute Peripartum Cardiomyopathy: Practical Guidance from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyJohann Bauersachs, Karen Sliwa, Mattia Arrigo et al.|European Journal of Heart Failure|2016Cited by 248